321 related articles for article (PubMed ID: 19097356)
21. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change.
Dhillon J; Amin MB; Selbs E; Turi GK; Paner GP; Reuter VE
Am J Surg Pathol; 2009 Jan; 33(1):44-9. PubMed ID: 18941398
[TBL] [Abstract][Full Text] [Related]
22. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin.
MacLennan GT; Farrow GM; Bostwick DG
Urology; 1997 Nov; 50(5):679-84. PubMed ID: 9372874
[TBL] [Abstract][Full Text] [Related]
23. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.
Srigley JR; Delahunt B; Eble JN; Egevad L; Epstein JI; Grignon D; Hes O; Moch H; Montironi R; Tickoo SK; Zhou M; Argani P;
Am J Surg Pathol; 2013 Oct; 37(10):1469-89. PubMed ID: 24025519
[TBL] [Abstract][Full Text] [Related]
24. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
25. The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification.
Skolarus TA; Serrano MF; Berger DA; Bullock TL; Yan Y; Humphrey PA; Kibel AS
J Urol; 2008 Feb; 179(2):439-43; discussion 443-4. PubMed ID: 18076932
[TBL] [Abstract][Full Text] [Related]
26. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
[TBL] [Abstract][Full Text] [Related]
27. Classification of renal neoplasms based on molecular signatures.
Yang XJ; Sugimura J; Schafernak KT; Tretiakova MS; Han M; Vogelzang NJ; Furge K; Teh BT
J Urol; 2006 Jun; 175(6):2302-6. PubMed ID: 16697863
[TBL] [Abstract][Full Text] [Related]
28. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms.
Cheng L; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R
Hum Pathol; 2009 Jan; 40(1):10-29. PubMed ID: 19027455
[TBL] [Abstract][Full Text] [Related]
29. [Putative chromophobe cell renal carcinoma: are they or are they not?].
Redondo Martínez E; Rey López A; de la Vega Pérez M; Camacho Galán R; Rivero Vera JC; Sánchez Lobo MV
Arch Esp Urol; 2001 Jun; 54(5):417-21. PubMed ID: 11494713
[TBL] [Abstract][Full Text] [Related]
30. Current insights in renal cell cancer pathology.
Mancini V; Battaglia M; Ditonno P; Palazzo S; Lastilla G; Montironi R; Bettocchi C; Cavalcanti E; Ranieri E; Selvaggi FP
Urol Oncol; 2008; 26(3):225-38. PubMed ID: 18452811
[TBL] [Abstract][Full Text] [Related]
31. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
Mai KT; Kohler DM; Robertson SJ; Belanger EC; Marginean EC
Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
[TBL] [Abstract][Full Text] [Related]
32. [Classification, histogenesis, and prognosis of renal cell carcinoma and renal oncocytoma].
Störkel S; Jacobi GH
Verh Dtsch Ges Pathol; 1989; 73():321-38. PubMed ID: 2482618
[TBL] [Abstract][Full Text] [Related]
33. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.
Cheng L; Williamson SR; Zhang S; Maclennan GT; Montironi R; Lopez-Beltran A
Expert Rev Anticancer Ther; 2010 Jun; 10(6):843-64. PubMed ID: 20553210
[TBL] [Abstract][Full Text] [Related]
34. [Characterization of renal cell carcinoma: current topics].
Kotake T; Kinouchi T
Gan To Kagaku Ryoho; 1994 Jan; 21(1):5-11. PubMed ID: 7507313
[TBL] [Abstract][Full Text] [Related]
35. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
36. Unusual case of multilocular cystic renal cell carcinoma treated with nephron-sparing technique.
Papadimitriou VG; Takos D; Adamopoulos V; Vegertaki U; Heretis JM; Stamatiou KN; Sofras FA
G Chir; 2009; 30(8-9):345-8. PubMed ID: 19735612
[TBL] [Abstract][Full Text] [Related]
37. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
38. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.
Kobayashi N; Matsuzaki O; Shirai S; Aoki I; Yao M; Nagashima Y
Hum Pathol; 2008 Sep; 39(9):1350-9. PubMed ID: 18602672
[TBL] [Abstract][Full Text] [Related]
39. Cytologic features of renal medullary carcinoma.
Assad L; Resetkova E; Oliveira VL; Sun W; Stewart JM; Katz RL; Caraway NP
Cancer; 2005 Feb; 105(1):28-34. PubMed ID: 15593260
[TBL] [Abstract][Full Text] [Related]
40. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
